Clinical Research

June 10, 2025

Why We’re Going to BIO (and Not Bringing a Booth)

BIO International Convention 2025 promotional graphic with the slogan "The World Can’t Wait," highlighting the event dates (June 16–19, 2025) and location at the Boston Convention & Exhibition Center, against a pink and orange biotech-inspired background.
BIO International Convention 2025 promotional graphic with the slogan "The World Can’t Wait," highlighting the event dates (June 16–19, 2025) and location at the Boston Convention & Exhibition Center, against a pink and orange biotech-inspired background.

Each year, thousands of biotech professionals converge for what can only be described as the world’s highest-concentration gathering of brainpower: the BIO International Convention. It’s where scientific breakthroughs are announced, capital flows in every direction, and partnering meetings blur into hallway pitches.

This year, Clinials will be there too. But we’re doing things a little differently this time.

We’re not coming with a booth.
We’re not pitching a molecule.
We’re not hosting a breakfast briefing at 7 a.m. in Ballroom G.

We’re coming to listen. To talk and ask questions. To observe the conversations that don’t always make it to the main stage.
And to turn those insights into something useful for the rest of the industry.

Listening Between the Lines

As a company focused on simplifying clinical trials, through plain language content, smarter workflows, and human-first design, we have a particular lens on the biotech space.

We’re not just watching the science evolve. We’re watching how people talk about it and how they act on it.
How information gets explained, how trust is built (or eroded), and how good ideas sometimes get lost in the fog of jargon and complexity.

At BIO, we’ll be tracking a few key themes:

  • AI and Trial Acceleration
    Who’s moving from hype to real-world implementation? What’s actually working?

  • Patient-Centricity in Practice
    How are companies moving from compliance-led approaches to meaningful inclusion?

  • Documentation, Trust, and Access
    How are sponsors and CROs making complex studies more accessible to sites, teams, and patients?

  • (Startup) Innovation in a Risk-Averse Environment
    What’s the appetite for tools like ours (or the FDA’s Elsa), especially when the industry is still learning how to evaluate emerging tech?

We’re Bringing the Mic - and Notebook

After MAGI Boston this year, we launched a new experiment: an informal video debrief, capturing authentic, unscripted insights from attendees across the spectrum; sites, sponsors, researchers, and more.

The result? One of our most-watched pieces of content to date. Real voices. Real takeaways.
No scripts. No fluff.

We’re planning to do something similar post-BIO.

You’ll find us in sessions, in side events, and probably on the sidelines with a recorder and a notepad.
We’re there to reflect and engage. And to bring forward the conversations that matter but sometimes don’t get airtime.

Let’s Talk (On or Off Camera)

If you’re heading to Boston and working in clinical trials, patient engagement, innovation strategy, or regulatory comms, we’d love to connect. Whether you want to chat about AI, trial documentation, or just share what’s surprised you at the event, say hi! 

You might just end up in our post-BIO wrap-up. Or better: leave with a few new ideas of your own.

See you at BIO 2025!

And…🎙️Watch this space for the post-event series.